Fantastic lecture and was great to meet you , looking forward to future collaborations .

EA 2192 is officially open UTSW Simmons Cancer Center! Enrolling patients with resected pancreatic cancer and a pathogenic BRCA1, BRCA2, or PALB2 mutation. See more below ecog-acrin.org/clinical-trial… Salwan Al Mutar MD MS Suzanne Cole, MD Syed Kazmi, M.D. Amy Little Jones, MD Shaalan Beg MD MBA FASCO Todd Aguilera MD PhD ECOG-ACRIN Cancer Research Group

Panc cx biochemical progression 3 months after surgery had gem/abx Ct DNA + chemo resumed FOLFIRI ca 19-9 still up Neuropathy hx of ckd crCL still above 50 , still clean scans likely peritoneal, even if proven can not put on trials due to lack of RESIST indx lesions ,ngs sent

Proud to co lead with the other awesome co directors Todd Aguilera MD PhD and Patricio Polanco .. learned a lot and Continuing on improving care and hope for pancreatic cancer patients. #4dcare

Unfortunately NOT great news for pancreatic cancer patients with HER2 From Destiny pantumor02 and 0% ORR for pancreatic cancer . In the pancreatic cohort, was observed in the first 15 patients, and the cohort was closed for further recruitment according futility criterion .

Great day for UTSW Simmons Cancer Center tomorrow! having the first post covid PDAC symposium. Pleasure to host Mike Pishvaian , looking forward to lots of learning! Patricio Polanco Todd Aguilera MD PhD Dr. Nina Niu Sanford Shaalan Beg MD MBA FASCO Tim Brown, MD MSCE Syed Kazmi, M.D. Nilesh Verma cme.utsouthwestern.edu/sites/default/…

Great event more to come UTSW Simmons Cancer Center

Excited for my debut with #ESMOGI24 . See you in Munich!🇩🇪

We can only keep going with this great group of people fighting it with us Congratulations to UTSW Simmons Cancer Center teams being in the top 3 teams with donations. #PurpleStride #oneteam PanCANDFW Todd Aguilera MD PhD Patricio Polanco Dr. Nina Niu Sanford Lan Vu UTSW Hematology & Oncology

Congratulations UT Southwestern Medical Center UTSW Medical School Class of 2024.

GI Poster session Baqir Jafry, MD presenting our work in the Flatiron Health database on post-progression therapies and outcomes for patients with BRCA mut panc can

Head onto poster #136 where we are discussing about our study and poor clinical trials/post hoc analyses on outcomes of BRCA mutated metastatic pancreatic cancer patients who progress on PARP inhibitors Syed Kazmi, M.D. Tim Brown, MD MSCE Salwan Al Mutar MD MS Kim Reiss Binder (Kim Reiss)

This video has me ready to RUN THROUGH A WALL. LETS GO. #DallasVsTheWorld Josephine Thinwa MD PhD utsouthwestern.edu/spark/

#followyourspark

Having a great debut with #GIESMO24 in Munich 🇩🇪 presenting the work led by Shaalan Beg MD MBA FASCO in UTSW Simmons Cancer Center with phase 1b Nintedenib +Gem +nab P in metastatic PDAC. ESMO - Eur. Oncology #pancreaticcancer

Thank you VJ Oncology for the opportunity to discuss our Study UTSW Simmons Cancer Center as well as some of the advances in Pancreatic cancer treatment at #GIesmo24🇩🇪 ESMO - Eur. Oncology vjoncology.com/video/cfxvennz…

Lets discuss the recent advances in treatment of PDAC and other cancers , privileged to join this fantastic team of experts UTSW Simmons Cancer Center

QI is not going to get you to Journal of Clinical Oncology or The Lancet Oncology BUT it will get you to Patients 💜s. proud of my Mentee Neha on finishing our project to improve early access of patient with metastatic PDAC to palliative care services UTSW Simmons Cancer Center Todd Aguilera MD PhD Patricio Polanco